Legal & General Group
KMTS

Legal & General Group’s Kestra Medical Technologies KMTS Stock Holding History

Legal & General Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256K Sell
12,826
-1,760
-12% -$41.5K ﹤0.01% 2496
2025
Q4 		$387K Buy
14,586
+13,152
+917% +$339K ﹤0.01% 2483
2025
Q3 		$34K Hold
1,434
– – ﹤0.01% 2830
2025
Q2 		$23.8K Buy
1,434
+434
+43% +$9.47K ﹤0.01% 2939
2025
Q1 		$24.9K Buy
+1,000
New +$23K ﹤0.01% 2873

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Legal & General Group's KMTS Position: Q1 2026 in Review

Legal & General Group reduced its Kestra Medical Technologies (KMTS) stake by 12% in Q1 2026, selling an estimated $41.5K and leaving 12,826 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Legal & General Group first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $387K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Legal & General Group held 12,826 shares of Kestra Medical Technologies worth $256K as of Q1 2026.
  • Legal & General Group sold 1,760 Kestra Medical Technologies shares in Q1 2026, an estimated $41.5K.
  • Kestra Medical Technologies made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2496 holding.
  • Legal & General Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Legal & General Group's Kestra Medical Technologies position peaked at $387K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.